Msn Laboratories Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is PEMIGATINIB, with a corresponding US DMF Number 38869.
Remarkably, this DMF maintains an Active status since its submission on November 04, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 09, 2024, and payment made on January 04, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II